23 May 2013
Keywords: viropharma, wyeth, start, ph, ii, trial, hcv
Article | 30 October 2006
USA-based biopharmaceutical company ViroPharma says that it has begun patient dosing in a Phase II trial of HCV-796, an oral ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 October 2006
22 May 2013
© 2013 thepharmaletter.com